Fredun Pharma - Quaterly Results

Fredun Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 539730 | NSE:

28 Jan 2022 Evaluate

The revenue for the December 2021 quarter is pegged at Rs. 542.33 millions, about 19.02% up against Rs. 455.68 millions recorded during the year-ago period.A good growth in profit of 40.01% reported to Rs. 18.72 millions over Rs. 13.37 millions of corresponding previous quarter.Operating profit surged to 43.55 millions from the corresponding previous quarter of 30.56 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202112	202012	% Var	202112	202012	% Var	202103	202003	% Var
Sales	542.33	455.68	19.02	1542.44	929.11	66.01	1315.52	1102.99	19.27
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	37.38	29.90	25.02
PBIDT	43.55	30.56	42.51	100.28	77.21	29.88	105.37	87.87	19.92
Interest	12.52	11.91	5.12	29.46	28.71	2.61	41.62	44.14	-5.71
PBDT	31.03	18.65	66.38	70.82	36.86	92.13	52.11	43.73	19.16
Depreciation	5.48	5.28	3.79	15.73	14.86	5.85	20.04	18.79	6.65
PBT	25.55	13.37	91.10	55.09	22.00	150.41	32.07	24.94	28.59
TAX	6.83	0.00	0.00	14.70	0.00	0.00	11.92	5.93	101.01
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	18.72	13.37	40.01	40.39	22.00	83.59	20.15	19.01	6.00
Equity	44.33	39.90	11.10	44.33	39.90	11.10	39.90	39.90	0.00
PBIDTM(%)	8.03	6.71	19.74	6.50	8.31	-21.77	8.01	7.97	0.54